News

Nifty Pharma has fallen by 12.8 per cent so far this year, with Natco Pharma and Granules India leading the plunge ...
Uncertainty surrounding potential US tariffs is threatening to disrupt India's booming pharma deal market, according to ...
Biotech startups, investors sharpen focus on the commercial potential of drugs to attract acquirers, partners.
The news of a likely import tariff hurt the share price of pharma giants like Novo Nordisk (NVO), Eli Lilly (LLY) and AstraZeneca (AZN), but Trump's announcement of a pause on reciprocal tariffs ...
AI4Beginners (English) on MSN14h
How Pharma is Reinventing Itself with AI
Pharmaceutical companies operate in one of the most complex regulatory and financial landscapes of any industry. They ...
The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.
For decades, the pharmaceutical industry has been defined by groundbreaking medical discoveries. But today, some of it ...
The threat of tariffs has put the pharma industry through the wringer this week. On Wednesday, a week after instituting widespread tariffs and a day after promising that “major” tariffs were headed ...
During the fourth quarter, the Harbor Health Care ETF returned –10.89%, underperforming the Russell 3000 Growth Health Care ...
The National Cancer Institute’s Investigational New Drug program facilitates collaboration, not collusion, with industry for ...
On April 9, 2025, the US Court of Appeals for the Federal Circuit held an oral argument on the company's appeal of the US ...
On The Readout LOUD podcast, STAT reporters talked with BIO's CEO John Crowley about RFK Jr. and tariffs, and discussed calls ...